News
A research team has successfully developed the world's first nasal organoid-based SARS-CoV-2 neutralizing antibody evaluation platform.
An organoid platform has been designed to enable accurate assessment of antibodies and vaccines against SARS-CoV-2.
A research team from the Department of Microbiology under the School of Clinical Medicine in the LKS Faculty of Medicine of the University of Hong Kong (HKUMed), has successfully developed the world’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results